
assessment of the future revenue and profitability opportunities resulting from the company's proposed merger with Eclipsys ECLP . For the quarter, revenue of $190 million and bookings of $119 million increased 14% and 15%, respectively, on a year
were interested to see that the first retention bonuses laid out in merger documents filed by medical-record company Eclipsys ( ECLP ) actually benefit the top officers of Allscripts (MDRX), which is buying Eclipsys for $1.3 billion or so in stock
Eclipsys ECLP management announced that the company will merge with Allscripts-Misys MDRX in an all-stock transaction. Under the terms of
Health-care IT spending shows signs of life, improving Eclipsys' near-term outlook.
Eclipsys ECLP management announced that the company will merge with Allscripts-Misys MDRX in an all-stock transaction. Under the terms of
On Wednesday, Allscripts-Misys MDRX and Eclipsys ECLP announced an all-stock merger transaction, making the future combined entity one of the largest providers of health-care IT
Eclipsys' ECLP fourth-quarter results met our expectations, and we are leaving our fair value estimate unchanged. Though the quarter's top
Eclipsys' ECLP third-quarter earnings met our expectations. We are maintaining our fair value estimate for now, although we might increase
We are increasing our fair value estimate for Eclipsys ECLP . The firm posted second-quarter results that slightly exceeded our expectations, and we see signs that the past year's lull
Eclipsys ECLP released first-quarter earnings that met our expectations. We are maintaining our fair value estimate. First-quarter revenue